FDA panel endorses lower-dose Moderna COVID shot for booster
United States health officials said Thursday that some Americans who received Moderna's COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk for COVID-19.
The recommendation is non-binding but it's a key step toward expanding the US booster campaign to millions of more Americans.
Many people who got their initial Pfizer shots at least six months ago are already getting a booster after the FDA authorised their use last month.
As for the dose, initial Moderna vaccination consists of two 100-microgram shots.
But Moderna says a single 50-microgram shot should be enough for a booster.
The agency convened its experts Thursday and Friday to weigh-in on who should get boosters and when for people that received the Moderna and Johnson & Johnson shots earlier this year.
The FDA will use its advisers' recommendations in making final decisions for boosters from both companies.
Assuming a positive decision, there's still another hurdle: Next week, a panel convened by the Centers for Disease Control and Prevention will offer more specifics on who should get one.
Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at email@example.com or firstname.lastname@example.org.